Total Funding
32
44
Total FundingVenture - Series Unknown raised
Growth Score
0 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
195633
AMBICION is a pharmaceutical company that develops innovative cancer treatments that address unmet medical needs.
Keigo Hanada: Vice President Director- Yoshiyuki Saito Saito: President and CEO
About the Company
AMBICION specializes in developing cancer immunotherapies targeting Natural Killer T cells. The company is advancing a proprietary pipeline, including RK-pulsed autologous and allogeneic antigen-presenting cells, to address unmet medical needs in oncology. It collaborates with renowned research institutions and aims to establish standard treatments
for cancer patients.
